News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hi-Tech Pharmacal (HITK) Reports Sales of $58.5 million for the Fourth Quarter Ended April 30, 2013


7/9/2013 6:26:38 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today reported results for the fourth quarter and year ended April 30, 2013.

•Net sales of $58.5 million for the fourth quarter compared to $61.3 million for the same prior year period
•GAAP loss of $4.6 million or $0.34 per diluted share for the fourth quarter
•Adjusted non-GAAP net income of $6.9 million or $0.50 per diluted share for the fourth quarter

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES